Anti-nucleocapsid (N) antibodies against COVID-19 (SARS-CoV-2) population estimates: March 2021 to January 2022
Exploratory modelled percentage of the population with levels of Anti-Nucleocapsid (N) antibodies against SARS-CoV-2 at or above 20 nanograms per millilitre (ng/ml) or 30 ng/ml, using data from the coronavirus (COVID-19) infection survey, by age group, UK countries.
Documents
Details
Official statistics are produced impartially and free from political influence.